New hematologic response criteria predict survival in patients with immunoglobulin light chain amyloidosis treated with high-dose melphalan and autologous stem-cell transplantation
- PMID: 23775968
- DOI: 10.1200/JCO.2013.48.7736
New hematologic response criteria predict survival in patients with immunoglobulin light chain amyloidosis treated with high-dose melphalan and autologous stem-cell transplantation
Comment in
-
Reply to S. Girnius et al.J Clin Oncol. 2013 Jul 20;31(21):2750-1. doi: 10.1200/JCO.2013.49.2512. J Clin Oncol. 2013. PMID: 24040662 No abstract available.
Comment on
-
New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes.J Clin Oncol. 2012 Dec 20;30(36):4541-9. doi: 10.1200/JCO.2011.37.7614. Epub 2012 Oct 22. J Clin Oncol. 2012. PMID: 23091105
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
